The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medifast Inc

NYSE: MED
Last

(U.S.) $42.79

Today's change-0.36 -0.83%
Updated March 24 11:06 AM EDT. Delayed by at least 15 minutes.
 

Medifast Inc

NYSE: MED
Last

(U.S.) $42.79

Today's change-0.36 -0.83%
Updated March 24 11:06 AM EDT. Delayed by at least 15 minutes.

Medifast Inc crosses below 50-day moving average

Medifast Inc is lower today, dropping (U.S.)$0.36 or 0.83% to (U.S.)$42.79 and crossing below its 50-day moving average. Shares have lost 1.81% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 30.70% during the last year.

Key company metrics

  • Open(U.S.) $43.31
  • Previous close(U.S.) $43.15
  • High(U.S.) $43.38
  • Low(U.S.) $42.67
  • Bid / Ask(U.S.) $42.70 / (U.S.) $42.78
  • YTD % change+2.79%
  • Volume37,137
  • Average volume (10-day)134,306
  • Average volume (1-month)91,175
  • Average volume (3-month)78,080
  • 52-week range(U.S.) $28.66 to (U.S.) $46.36
  • Beta0.58
  • Trailing P/E28.66×
  • P/E 1 year forward21.10×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.28
  • Dividend yield2.99%
  • Trailing EPS(U.S.) $1.49
Updated March 24 11:06 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.50%

Based on its net profit margin of 6.50%, Medifast Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.33%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue62697172
Total other revenue--------
Total revenue62697172
Gross profit47525353
Total cost of revenue15161819
Total operating expense56606666
Selling / general / administrative40434847
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income7956
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax7956
Income after tax4634
Income tax, total3322
Net income4634
Total adjustments to net income--------
Net income before extra. items4634
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4634
Inc. avail. to common incl. extra. items4634
Diluted net income4634
Dilution adjustment--------
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.340.510.290.36
Dividends per sharevalue per share0.320.250.250.25
Diluted normalized EPSvalue per share0.340.510.290.36